• Smoothened Function in Honeybee Olfaction: Insights from Smo

  2026-07-24

  Guo et al. (2024) provide the first molecular and functional characterization of the Smoothened (Smo) protein in Apis mellifera, demonstrating that Hedgehog pathway modulation directly influences olfactory receptor expression and sensory-driven behavior. These findings establish a new model for understanding insect sensory biology and highlight the utility of small molecule Smo agonists in functional assays.

• Berberine Hydrochloride: Applied Workflows in Metabolic and

  2026-07-23

  Berberine Hydrochloride stands out for its dual action in modulating metabolic and inflammatory pathways, offering reproducible workflows across diverse preclinical models. This article distills bench-tested protocols, troubleshooting expertise, and cutting-edge insights from acute kidney injury—enabling researchers to harness APExBIO’s high-purity reagent for robust, translational results.

• Dextran Sulfate Sodium Salt: Illuminating Epithelial Repair

  2026-07-23

  Explore how Dextran sulfate sodium salt (MW 35000-45000) uniquely models epithelial barrier disruption and repair in ulcerative colitis research. This article integrates recent mechanistic insights and practical guidance for advanced preclinical study design.

• Sumatriptan Succinate: Optimized Workflows for 5-HT1 Researc

  2026-07-22

  Sumatriptan Succinate, a benchmark 5-HT1 receptor agonist, enables precise interrogation of serotonergic and neuroinflammatory pathways in migraine and inflammation models. This guide translates the latest metabolic insights and advanced troubleshooting tips into actionable experimental workflows for reproducible, high-impact research.

• (-)-Blebbistatin in Mechanotransduction: A New Frontier for

  2026-07-22

  Explore how (-)-Blebbistatin, a potent non-muscle myosin II inhibitor, uniquely empowers advanced mechanotransduction research. This article reveals emerging insights into cell mechanics and practical assay design, bridging cytoskeletal dynamics with GPCR mechanosensing.

• Caspase-1 Inhibition Restores Blood-Brain Barrier Integrity

  2026-07-21

  The study by Israelov et al. demonstrates that caspase-1 plays a central role in blood-brain barrier (BBB) injury, and its selective inhibition with VX-765 robustly restores barrier function in vitro and in vivo. These findings highlight caspase-1 as a therapeutic target for CNS disorders involving BBB disruption, offering mechanistic insight for researchers exploring neuroinflammation.

• Sodium dicloxacillin monohydrate: Precision for MSSA Workflo

  2026-07-21

  Sodium dicloxacillin monohydrate bridges robust in vitro and in vivo methods for dissecting MSSA antibiotic responses and mechanism. This guide translates reference-driven insights into actionable protocols and troubleshooting, empowering researchers to design reliable Gram-positive infection studies with APExBIO’s trusted compound.

• AM 281: Transforming CB1 Cannabinoid Receptor Antagonist Res

  2026-07-20

  AM 281 stands out as a potent and selective CB1 cannabinoid receptor antagonist, enabling researchers to dissect neuropharmacological pathways with precision. Its validated performance in TBI, memory impairment, and addiction models unlocks new levels of reproducibility and translational insight.

• EdU Imaging Kits (HF594): Precision Tools for Proliferation

  2026-07-20

  Explore how EdU Imaging Kits (HF594) enable high-precision DNA synthesis measurement in advanced cell proliferation assays, with a focus on overcoming drug resistance in cancer research. This article moves beyond protocol basics to reveal mechanistic insights and translational applications.

• Berberrubine Chloride: Mechanistic Precision for Metabolic D

  2026-07-19

  Explore the multifaceted mechanisms and translational applications of Berberrubine chloride, an advanced isoquinoline alkaloid for metabolic and cancer research. This deep-dive uniquely integrates biochemical innovation with protocol guidance, setting it apart from prior content.

• PDHA1 Succinylation Modulates Immune Escape in Cholangiocarc

  2026-07-18

  This study uncovers how succinylation of PDHA1 at lysine 83 in cholangiocarcinoma drives alpha-ketoglutaric acid (α-KG) accumulation, leading to suppressed macrophage antigen presentation and tumor immune evasion. Inhibiting this modification with CPI-613 enhances chemotherapy sensitivity, offering a targeted metabolic approach to overcoming resistance in this aggressive cancer.

• GSK2606414: Precision PERK Inhibition Unlocks New Frontiers

  2026-07-17

  Explore how GSK2606414, a potent PERK inhibitor, advances ER stress research and disease modeling. This article provides deep mechanistic insight and protocol guidance distinct from existing content.

• AM 281 and the CB1-CREB Axis: Precision Tools for Cognitive

  2026-07-17

  Explore how AM 281, a potent CB1 cannabinoid receptor antagonist, enables advanced research into glutamate homeostasis, neuronal survival, and memory impairment. This article reveals unique assay insights and protocol guidance, going beyond standard neuropharmacology workflows.

• RCN2 Drives Metastasis and Cisplatin Resistance in ESCC via

  2026-07-16

  This study identifies Reticulocalbin 2 (RCN2) as a key driver of metastasis and cisplatin resistance in esophageal squamous cell carcinoma (ESCC) through UBR5-mediated degradation of PPP2CA and subsequent activation of the PI3K-AKT pathway. The findings highlight RCN2 as a potential therapeutic target for overcoming treatment resistance in ESCC.

• CX-5461 in Cancer Research: Mechanisms, Selectivity, and Pro

  2026-07-16

  Explore how CX-5461, a potent RNA polymerase I inhibitor, enables targeted cancer research through selective rRNA synthesis inhibition. This article delivers advanced mechanistic insights and practical guidance distinct from standard workflows.

447 records 10/30 page Previous Next First page 上5页 678910 下5页 Last page